@prefix biolink: . @prefix infores: . @prefix np: . @prefix npx: . @prefix orcid: . @prefix pav: . @prefix prov: . @prefix rdf: . @prefix rdfs: . @prefix sub: . @prefix this: . @prefix xsd: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { a biolink:ChemicalEntity; rdfs:label "Quazepam"; biolink:category biolink:ChemicalEntity . a biolink:DiseaseOrPhenotypicFeature; rdfs:label "insomnia"; biolink:category biolink:DiseaseOrPhenotypicFeature . sub:_1 rdf:object ; rdf:predicate biolink:treats; rdf:subject ; a biolink:Association; biolink:aggregator_knowledge_source infores:knowledge-collaboratory; biolink:category biolink:Association; biolink:publications . } sub:provenance { sub:assertion prov:generatedAtTime "2022-10-24T09:02:36.234884"^^xsd:dateTime; prov:wasAttributedTo orcid:0000-0002-1501-1082; prov:wasQuotedFrom "Quazepam is indicated for the treatment of insomnia characterized by difficulty in falling asleep, frequent nocturnal awakenings, and/or early morning awakenings." . biolink: pav:version "2.3.0" . } sub:pubinfo { sub:sig npx:hasAlgorithm "RSA"; npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCR9fz0fKCdWOWC+pxhkQhEM/ppbdIYe5TLSdj+lJzSlv9mYBaPgrzVezSwwbmhlHBPDZa4/vHycU315BdmUGq+pXllp9+rWFfrb+kBJwhZjpG6BeyyXBsRFz4jmQVxl/ZYHilQTh/XalYzKkEAyTiEMPee4Kz61PaWOKH24CsnOQIDAQAB"; npx:hasSignature "W0yQA/4yo0tqg08MddmOcOmUPKUBfNkBUaBV5LCcET16hf0YiJFm+qq2jelP3bwY9lUkglVLTKI7KiMUrxDSap8rRMANb8D/7dU6FpqE/Tc3NLzZhlR+WguADJRxJ9JAvxD3RiSnVVihTdGMp+qSKlLmHNZur9liCccB/gqUk04="; npx:hasSignatureTarget this: . this: prov:generatedAtTime "2022-10-24T09:02:36.234884"^^xsd:dateTime; prov:wasAttributedTo orcid:0000-0002-1501-1082 . }